1. Home
  2. NLSP vs WAFU Comparison

NLSP vs WAFU Comparison

Compare NLSP & WAFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • WAFU
  • Stock Information
  • Founded
  • NLSP 2015
  • WAFU 1999
  • Country
  • NLSP Switzerland
  • WAFU China
  • Employees
  • NLSP N/A
  • WAFU N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • WAFU Other Consumer Services
  • Sector
  • NLSP Health Care
  • WAFU Real Estate
  • Exchange
  • NLSP Nasdaq
  • WAFU Nasdaq
  • Market Cap
  • NLSP 12.4M
  • WAFU 6.5M
  • IPO Year
  • NLSP 2021
  • WAFU 2019
  • Fundamental
  • Price
  • NLSP $2.86
  • WAFU $1.42
  • Analyst Decision
  • NLSP
  • WAFU
  • Analyst Count
  • NLSP 0
  • WAFU 0
  • Target Price
  • NLSP N/A
  • WAFU N/A
  • AVG Volume (30 Days)
  • NLSP 365.2K
  • WAFU 14.7K
  • Earning Date
  • NLSP 07-07-2025
  • WAFU 01-01-0001
  • Dividend Yield
  • NLSP N/A
  • WAFU N/A
  • EPS Growth
  • NLSP N/A
  • WAFU N/A
  • EPS
  • NLSP N/A
  • WAFU N/A
  • Revenue
  • NLSP N/A
  • WAFU $6,374,594.00
  • Revenue This Year
  • NLSP N/A
  • WAFU N/A
  • Revenue Next Year
  • NLSP N/A
  • WAFU N/A
  • P/E Ratio
  • NLSP N/A
  • WAFU N/A
  • Revenue Growth
  • NLSP N/A
  • WAFU N/A
  • 52 Week Low
  • NLSP $1.30
  • WAFU $1.22
  • 52 Week High
  • NLSP $15.59
  • WAFU $7.49
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 67.56
  • WAFU 52.27
  • Support Level
  • NLSP $2.19
  • WAFU $1.36
  • Resistance Level
  • NLSP $2.54
  • WAFU $1.45
  • Average True Range (ATR)
  • NLSP 0.19
  • WAFU 0.06
  • MACD
  • NLSP 0.02
  • WAFU 0.00
  • Stochastic Oscillator
  • NLSP 82.76
  • WAFU 76.92

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About WAFU Wah Fu Education Group Limited

Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services, and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.

Share on Social Networks: